Naropin Dosage
Generic name: ropivacaine
Brand names: Naropin, Naropin Polyamp, Naropin SDV
Drug class: Local injectable anesthetics
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: INJ (0.2%): 2 mg per mL; INJ (0.5%): 5 mg per mL; INJ (0.75%): 7.5 mg per mL; INJ (1%): 10 mg per mL
Regional anesthesia, surgery
- [lumbar block, cesarean section]
- Dose: 100-150 mg (0.5% conc.) epidurally x1; Alt: 113-150 mg (0.75% conc.) epidurally x1; Info: onset 10-25min, duration 2-5h
- [lumbar block, all other procedures]
- Dose: 75-150 mg (0.5% conc.) epidurally x1; Alt: 113-188 mg (0.75% conc.) epidurally x1; 150-200 mg (1% conc.) epidurally x1; Info: onset 10-30min, duration 2-6h
- [thoracic block]
- Dose: 25-75 mg (0.5% conc.) epidurally x1; Alt: 38-113 mg (0.75% conc.) epidurally x1; Info: onset 10-20min
- [peripheral nerve block, major]
- Dose: 175-250 mg (0.5% conc.) perineurally x1; Alt: 75-300 mg (0.75% conc.) perineurally x1; Info: onset 10-30min, duration 5-10h
- [peripheral nerve block, minor]
- Dose: 5-200 mg (0.5% conc.) perineurally x1; Info: onset 1-15min, duration 2-6h
Local anesthesia, surgery
- [infiltration]
- Dose: 5-200 mg (0.5% conc.) via infiltration x1; Info: onset 1-15min, duration 2-6h
Labor pain
- [lumbar block]
- Dose: 12-28 mg/h (0.2% conc.) epidurally; Start: 20-40 mg (0.2% conc.) epidurally x1; Info: titrate to effect
Regional analgesia, postop
- [lumbar block]
- Dose: 12-28 mg/h (0.2% conc.) epidurally; Info: titrate to effect
- [thoracic block]
- Dose: 12-28 mg/h (0.2% conc.) epidurally; Info: titrate to effect
- [peripheral nerve block, minor]
- Dose: 5-200 mg (0.5% conc.) perineurally x1; Alt: 2-200 mg (0.2% conc.) perineurally x1; Info: onset 1-5min, duration 2-6h
Local analgesia, postop
- [infiltration]
- Dose: 5-200 mg (0.5% conc.) via infiltration x1; Alt: 2-200 mg (0.2% conc.) via infiltration x1; Info: onset 1-5min, duration 2-6h
Renal dosing
- renal impairment: consider decr. usual dose
- HD/PD: not defined
Hepatic dosing
- [not defined]
- hepatic impairment: caution advised
SRC: NLM .